Get the Stockscreener App
7.02
6.20%
0.41
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $7.02, with a volume of 3.26M.
It is up +6.20% in the last 24 hours and up +8.84% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
See More
Previous Close:
$6.61
Open:
$6.58
24h Volume:
3.26M
Relative Volume:
1.47
Market Cap:
$2.60B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-14.62
EPS:
-0.48
Net Cash Flow:
$1.01B
1W Performance:
+13.23%
1M Performance:
+8.84%
6M Performance:
+32.45%
1Y Performance:
-23.70%
1-Day Range:
$6.58
$7.175
1-Week Range:
$5.875
$7.175
52-Week Range:
$4.25
$9.85
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
7.02 | 2.45B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
Bausch Health Companies Inc. (BHC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Bausch Health raises 2025 revenue guidance to $5B-$5.1B while strengthening Solta and Salix growth - MSN
Bausch Health Cos (NYSE:BHC) Shares Gap UpHere's What Happened - MarketBeat
Bausch Health Companies (TSE:BHC) Stock Price Up 15.9%Here's Why - MarketBeat
5 Undervalued Stocks Under $10 Poised for Double-Digit Rebounds - Investing.com
Europe Photodynamic Therapy Market Size, Trends, Leading Applications and Pricing Benchmarks (2025-2033) Featuring Gladerma, Sun Pharmaceutical, Biofrontera, Lumibird, Bausch Health Companies and More - GlobeNewswire
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Wave Life Sciences (WVE) and Bausch Health Companies (BHC) - The Globe and Mail
Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS) - The Globe and Mail
Bausch Health Companies Inc. (NYSE:BHC) Q3 2025 Earnings Call Transcript - MSN
Why Bausch Health Is A Buy After Rising 10% On Third Quarter Results - Seeking Alpha
Is Bausch Health Companies Inc. stock supported by strong fundamentalsLong Setup & Free Technical Confirmation Trade Alerts - newser.com
What RSI levels show for Bausch Health Companies Inc. stockJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Should you wait for a breakout in Bausch Health Companies Inc.Entry Point & Safe Entry Momentum Stock Tips - newser.com
Is Bausch Health Companies Inc. stock a smart buy before Fed meetingDollar Strength & Growth Focused Investment Plans - newser.com
Is Bausch Health Companies Inc. stock positioned for digital transformationJuly 2025 Institutional & Fast Momentum Stock Entry Tips - newser.com
Can Bausch Health Companies Inc. stock rebound after recent weaknessJuly 2025 Catalysts & Community Consensus Stock Picks - newser.com
How Bausch Health Companies Inc. stock reacts to fiscal policiesSell Signal & Community Consensus Trade Alerts - newser.com
Institutional scanner results for Bausch Health Companies Inc.July 2025 Opening Moves & Reliable Trade Execution Plans - newser.com
Published on: 2025-10-31 00:48:51 - newser.com
How to interpret RSI for Bausch Health Companies Inc. stock2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Bausch Health Companies Inc (BHC) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Bausch Health (BHC) Q3 2025 Earnings Transcript - AOL.com
Bausch Health Turns A Profit And Lifts Its Outlook - Finimize
Bausch: Q3 Earnings Snapshot - CTPost
BHC Stock Up on Q3 Earnings Beat, Salix and Solta Drive Sales - TradingView
Bausch Health Companies Inc. SEC 10-Q Report - TradingView
Will Bausch Health Companies Inc. stock sustain high P E ratiosJuly 2025 Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Bausch Health Companies Inc. stock bottoming out2025 Investor Takeaways & Weekly Momentum Picks - newser.com
How supply chain issues affect Bausch Health Companies Inc. stockPortfolio Risk Report & AI Driven Stock Movement Reports - newser.com
Why analysts remain bullish on Bausch Health Companies Inc. stockIPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Published on: 2025-10-30 00:49:28 - newser.com
Is Bausch Health Companies Inc. (BVF) stock worth buying before Fed action2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Bausch Health Q3 Adjusted Earnings and Revenue, Advance - 富途牛牛
Bausch Health Companies Turns To Profit In Q3; Stock Up In After-hours - Nasdaq
Bausch Health Companies Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Bausch Health Raises Forecast After Beating Expectations Again - Finimize
Bausch Health rises on 2025 revenue, EBITDA guidance boost, Q3 beats - Seeking Alpha
Bausch & Lomb Corp SEC 10-Q Report - TradingView
Bausch Health Brief: Q3 GAAP Net Income Attributable of US$179 Million and GAAP Net Income of $181 Million - MarketScreener
Bausch Health Announces Third Quarter 2025 Results - ACCESS Newswire
Bausch Health leaves Medicaid, 340B program, STAT reports - TipRanks
Zacks Research Issues Pessimistic Outlook for BHC Earnings - MarketBeat
What is Zacks Research's Forecast for TSE:BHC Q3 Earnings? - MarketBeat
Is Bausch Health Companies Inc. stock inflation resilient2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):